Cilomni-10/40 — Cilnidipine IP 10 mg and Telmisartan IP 40 mg, along with approved excipients
Cilomni-T 10/40 by EMK Omni Pharma is a prescription-based Cilnidipine and Telmisartan Tablets formulation used for doctor-supervised hypertension man...

What is Cilomni-10/40?
Cilomni-10/40 is a pharmaceutical product manufactured and marketed by EMK Omni Pharma, a trusted pharmaceutical company based in Mysuru, Karnataka. It belongs to the Blood Pressure Management therapeutic category and is available as a Tablet formulation.
Cilomni-T 10/40 by EMK Omni Pharma is a prescription-based Cilnidipine and Telmisartan Tablets formulation used for doctor-supervised hypertension management, blood pressure control, and cardiovascular health support. Each film-coated tablet contains Cilnidipine IP 10 mg and Telmisartan IP 40 mg. Cilomni-T 10/40 is designed for patients who require combination therapy support for high blood pressure, vascular health, heart care, and long-term cardiovascular risk management. Cilomni-T 10/40 Cilnidipine 10 mg and Telmisartan 40 mg Tablets by EMK Omni Pharma are commonly prescribed by healthcare professionals as part of a physician-guided treatment plan for hypertension, elevated blood pressure, cardiac protection, and blood vessel relaxation support. This medicine should be used only under the supervision of a registered medical practitioner.
Composition & Active Ingredients
Each tablet of Cilomni-10/40 contains the following active pharmaceutical ingredients:
Active Composition: Cilnidipine IP 10 mg and Telmisartan IP 40 mg, along with approved excipients
Dosage Strength: 10 mg & 40 mg
Medicine Type: Tablet
Pack Size: 10 X 10 Tablets
The formulation is prepared with approved excipients to ensure optimal stability, bioavailability, and therapeutic efficacy. All ingredients comply with Indian Pharmacopoeia (IP) standards where applicable.
Therapeutic Category — Blood Pressure Management
Cilomni-10/40 is classified under the Blood Pressure Management therapeutic category. This category encompasses medicines that are commonly prescribed by healthcare professionals for conditions related to hypertension, blood pressure control, heart rate regulation, cardiac workload reduction, and vascular health.
Cilomni-T 10/40 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, vascular resistance, and cardiovascular risk factors. It may be used as part of a complete physician-guided heart care plan for individuals who need blood pressure control and long-term cardiovascular health management. Cilomni-T 10/40 by EMK Omni Pharma is suitable for doctor-supervised treatment where combination support for hypertension, blood pressure management, and cardiac health is required. Patients should not self-medicate, change the dosage, stop the medicine, or combine it with other medicines without consulting their doctor. Telmisartan should be discontinued as soon as pregnancy is detected, as advised on the product label, and patients must consult their physician immediately in such cases.
Dosage Strength & Formulation
Cilomni-10/40 is formulated as a Tablet with a dosage strength of 10 mg & 40 mg. It is available in a pack size of 10 X 10 Tablets.
This product is designed for oral administration and should be taken exactly as prescribed by a registered medical practitioner. Patients should not alter the dosage, crush, chew, or break the tablet unless specifically instructed by their physician.
Important: The dosage and duration of treatment are determined by the prescribing physician based on the patient's individual medical condition, age, weight, and response to treatment.
Storage Instructions
Proper storage of pharmaceutical products is essential to maintain their quality, potency, and safety. Cilomni-10/40 should be stored according to the following guidelines:
Cilomni-T 10/40 Cilnidipine and Telmisartan Tablets should be stored in a cool, dark, and dry place, protected from light and moisture.
General Storage Guidelines:
Prescription & Regulatory Information
Cilomni-10/40 is a prescription-based pharmaceutical product. It must only be dispensed and used under the guidance of a registered medical practitioner.
Prescription Warning: Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
This medicine is regulated under Indian pharmaceutical laws and is subject to Schedule H / Schedule G drug regulations as applicable. It should not be purchased or used without a valid prescription from a licensed healthcare professional.
For Healthcare Professionals: Cilomni-10/40 is available through authorised pharmaceutical distribution channels. For product availability, pricing, and distribution enquiries, please contact EMK Omni Pharma directly.
Caution, Safety & Important Warnings
Caution Details: The medicine must be kept out of reach of children and used only as directed by the physician.
General Safety Information:
About EMK Omni Pharma
EMK Omni Pharma is a trusted pharmaceutical company based in Mysuru, Karnataka, operating as Under the visionary leadership of Kumara Swamy, the company is committed to providing high-quality, physician-guided pharmaceutical products across multiple therapeutic areas.
Our product portfolio includes medicines for Cardiac Care, Cholesterol & Lipid Care, Blood Pressure Management, Nutritional Supplements, Pain Management, and Diabetes Care, all formulated to meet established pharmaceutical quality standards. EMK Omni Pharma works closely with healthcare professionals, pharmacies, hospitals, and distribution partners to ensure that quality medicines reach those who need them — safely, reliably, and responsibly.
Office Address: 2nd Floor, Room No. 01, 102A, Panchamantra Rd, above Kumar Medicals, Kuvempu Nagara, Mysuru, Karnataka 570023
Email: info@emkomnipharma.com
Medical Disclaimer
The information provided on this page is intended for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations.
This product information should not be used as a substitute for professional medical advice. Always consult a qualified and registered medical practitioner before starting, stopping, or changing any medication. Self-medication can be harmful and may lead to serious health consequences.
EMK Omni Pharma does not make any therapeutic claims about curing, treating, or preventing any disease without proper clinical evidence and regulatory approval. All products are intended for use only under proper medical supervision.
The product details, composition, and usage guidelines mentioned here are based on the manufacturer's product information and are subject to change. For the most current product information, please refer to the actual product packaging or consult your healthcare provider.
Related Articles
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.


